This is a live activity that occurred on November 13, 2022. If you attended this activity in person and would like to claim CME credit or a certificate of participation, please click “Take Quiz”.
Lyme disease is the most common vector-borne disease in the United States and its incidence is expected to increase with climate change. Most cases of Lyme disease can be cured with a course of oral antibiotics. However, some patients have concerns about persistent symptoms they attribute to Lyme disease. Physicians often find it challenging to treat these patients due to the lack of evidence-based guidance and growing patient exposure to misinformation. The AMA, with support from the Centers for Disease Control and Prevention, collected expert opinions from physicians (n=25) from a range of specialties (primary care, neurology, rheumatology, psychiatry, and infectious diseases) through in-depth interviews and focus groups to inform guidance on evaluating and treating patients with concerns for persistent symptoms attributed to Lyme disease. In this interactive session, participants will learn about the initial findings of this study. Participants will be able to describe sources and types of misinformation that patients might be exposed to and explain best practices in responding to patient concerns. Participants will take part in breakout discussions to learn from colleagues and share their own experiences managing patients, addressing misinformation, and evaluating resources that could support physicians in treating these patient.
Sign in to take quiz and track your certificates
The AMA Ed Hub™
is a unified education portal that provides a personalized experience for physicians and their care teams to keep current, increase their professional satisfaction, claim continuing education credits and continuously improve the care they provide–leading to real world outcomes of better healthcare and better health for their patients. Learn more
AMA CME Accreditation Information
Credit Designation Statement: The American Medical Association designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. Arnold Chen, MD: Merk Sharp & Dohme LLC, Contracted Research; Edwards Lifesciences, Contracted Research.
All relevant financial relationships have been mitigated.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:
1.5 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program;
1.5 Self-Assessment points in the American Board of Otolaryngology – Head and Neck Surgery’s (ABOHNS) Continuing Certification program;
1.5 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program; and
1.5 Lifelong Learning points in the American Board of Pathology’s (ABPath) Continuing Certification program;
It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting MOC credit.
You currently have no searches saved.
You currently have no courses saved.